Biomerica (BMRA) Cash from Investing Activities (2016 - 2025)
Biomerica's Cash from Investing Activities history spans 16 years, with the latest figure at -$4000.0 for Q1 2025.
- On a quarterly basis, Cash from Investing Activities rose 75.0% to -$4000.0 in Q1 2025 year-over-year; TTM through May 2025 was -$44000.0, a 61.74% increase, with the full-year FY2025 number at -$37000.0, up 67.83% from a year prior.
- Cash from Investing Activities hit -$4000.0 in Q1 2025 for Biomerica, up from -$24000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for BMRA hit a ceiling of -$4000.0 in Q1 2025 and a floor of -$100539.0 in Q1 2021.
- Historically, Cash from Investing Activities has averaged -$35965.4 across 5 years, with a median of -$24000.0 in 2022.
- Biggest five-year swings in Cash from Investing Activities: crashed 231.53% in 2021 and later soared 81.25% in 2022.
- Tracing BMRA's Cash from Investing Activities over 5 years: stood at -$49613.0 in 2021, then soared by 51.63% to -$24000.0 in 2022, then soared by 50.0% to -$12000.0 in 2023, then plummeted by 100.0% to -$24000.0 in 2024, then skyrocketed by 83.33% to -$4000.0 in 2025.
- Business Quant data shows Cash from Investing Activities for BMRA at -$4000.0 in Q1 2025, -$24000.0 in Q2 2024, and -$16000.0 in Q1 2024.